Donor eyes were cut into small sections consisting of sclera,
choroid, and retina and fresh frozen in optimal temperature cutting
compound (OCT; Miles, Elkhart, IN). Alternatively, the retina was first
removed from the choroid and then fresh frozen in OCT. Serial sections
were cut, air-dried, and acetone fixed. Blocking with normal horse
serum and for endogenous avidin and biotin prevented background
staining. The primary antibody was mouse anti-human CD11b (PharMingen
1:20). The secondary antibody, a biotin-labeled horse anti-mouse IgG
(Vectastain; Vector, Burlingame, CA), was added and visualized using
streptavidin and biotinylated horseradish peroxidase complex (sABC) and
diaminobenzidine tetrahydrochloride (DAB), according to the
manufacturer’s instructions. The process was then repeated using the
required second primary antibody at previously established optimal
dilutions (CD45 1:50, MHC class II 1:100, CD40 1:25, CD86 1:50, and
CD68 1:100). The secondary biotin-labeled antibody was this time
visualized using sABC and an alkaline phosphatase–anti-alkaline
phosphatase (APAAP) substrate, according to the manufacturer’s
instructions. Negative controls were IgG isotype matched. Sections were
lightly counterstained in dilute hematoxylin. For fluorescence
staining, primary antibodies were labeled using goat anti-mouse FITC
(Serotec, Oxford, UK) and sections counterstained using π mounting
fluid (Apoptag Kit; Oncor, Gaithersburg, MD).